Sonographic measurement of cervical length and fetal fibronectin testing in threatened preterm labor

Ultrasound in Obstetrics and Gynecology

Volumn 27, Issue 4, 2006, Pages 368-372

  Tsoi, E ^a   Akmal, S ^a   Geerts, L ^b   Jeffery, B ^c   Nicolaides, K H ^a,d  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c UNIVERSITY OF PRETORIA   (South Africa)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cervical length; Fetal fibronectin; Preterm labor; Sonography

Indexed keywords

FETOPROTEIN; FIBRONECTIN; UTERUS SPASMOLYTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; FETUS MEMBRANE; GESTATIONAL AGE; HUMAN; IMMINENT ABORTION; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MATERNAL AGE; PARITY; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DILATATION; UTERUS CONTRACTION;

ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; CERVIX UTERI; CONTINENTAL POPULATION GROUPS; FEMALE; FIBRONECTINS; GESTATIONAL AGE; GLYCOPROTEINS; HUMANS; LOGISTIC MODELS; MATERNAL AGE; OBSTETRIC LABOR, PREMATURE; PARITY; PREGNANCY; PREGNANCY TRIMESTER, THIRD; RECURRENCE; REGRESSION ANALYSIS; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 33646671267     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.2723     Document Type: Article

References (23)

1. Gyetvai K, Hannah M, Hodnett E, Ohlsson A. Tocolytics for preterm labor: a systematic review. Obstet Gynecol 1999; 94: 869-877.
2. King J F, Grant A, Keirse M, Chalmers I. Beta-mimetics in preterm labour: an overview of the randomized controlled trials. Br J Obstet Gynaecol 1988; 95: 211-222.
3. Tsoi E, Akmal S, Rane S, Otigbah C, Nicolaides KH. Ultrasound assessment of cervical length in threatened preterm labour. Ultrasound Obstet Gynecol 2003; 21: 552-555.
4. Fuchs IB, Henrich W, Osthues K, Dudenhausen JW. Sonographic cervical length in singleton pregnancies with intact membranes presenting with threatened preterm labor. Ultrasound Obstet Gynecol 2004; 24: 554-557.
5. Tsoi E, Geerts L, Jeffery B, Odendaal HJ, Nicolaides KH. Sonographic cervical length in threatened preterm labor in a South African population. Ultrasound Obstet Gynecol 2004; 24: 644-646.
6. Iams J, Casal D, McGregor JA, Goodwin TM, Kreaden US, Lowensohn R, Lockitch G. Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol 1995; 173: 141-145.
7. Bartnicki J, Casal D, Seshardri Kreaden U, Saling E, Vetter K. Fetal fibronectin in vaginal specimens predicts preterm delivery and very low birth weight infants. Am J Obstet Gynecol 1996; 174: 971-974.
8. Malak TM, Sizmur F, Bell SC, Taylor DJ. Fetal fibronectin in cervicovaginal secretions as a predictor of preterm birth. Br J Obstet Gynaecol 1996; 103: 648-653.
9. Senden IPM, Owen P. Comparison of cervical assessment, fetal fibronectin and fetal breathing in the diagnosis of preterm labour. Clin Exp Obstet Gynecol 1996; 23: 5-9.
10. Benattar C, Taieb J, Fernandez H, Lindendaum A, Frydman R, Ville Y. Rapid fetal fibronectin swab-test in preterm labor patients treated by betamimetics. Eur J Obstet Gynecol Reprod Biol 1997; 72: 131-135.
11. Peaceman AM, Andrews WW, Thorp JM, Cliver SP, Lukes A, lams JD, Coultrip L, Eriksen N, Holbrook RH, Elliott J, Ingardia C, Pietrantoni M. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: A multicenter trial. Am J Obstet Gynecol 1997; 177: 13-18.
12. Coleman MA, McCowan LM, Pattison NS, Mitchell M. Fetal fibronectin detection in preterm labor: Evaluation of a prototype bedside dipstick technique and cervical assessment. Am J Obstet Gynecol 1998; 179: 1553-1558.
13. McKenna DS, Chung K, lams JD. Effect of digital cervical examination on the expression of fetal fibronectin. J Reprod Med 1999; 44: 796-800.
14. Giles W, Bisits A, Knox M, Madsen G, Smith R. The effect of fetal fibronectin testing on admissions to a tertiary maternal fetal medicine unit and cost savings. Am J Obstet Gynecol 2000; 182: 439-442.
15. Coleman MA, Keelan JA, McCowan LM, Townend KM, Mitchell MD. Predicting preterm delivery: comparison of cervicovaginal interleukin (IL)-1β, IL-6 and IL-8 with fetal fibronectin and cervical dilatation. Eur J Obstet Gynecol Reprod Biol 2001; 95: 154-158.
16. Rinehart BK, Terrone DA, Isler CM, Scott Barrilleaux P, Bufkin L, Morrison JC. Pregnancy outcome in women with preterm labor symptoms without cervical change. Am J Obstet Gynecol 2001; 184: 1004-1007.
17. Heath V, Southall T, Souka A, Novakov A, Nicolaides KH. Cervical length at 23 weeks of gestation: relation to demographic characteristics and previous obstetric history. Ultrasound Obstet Gynecol 1998; 12: 304-311.
18. Rizzo G, Capponi A, Arduini D, Lorido C, Romanini C. The value of fetal fibronectin in cervical and vaginal secretions and of ultrasonographic examination of the uterine cervix in predicting premature delivery for patients with preterm labor and intact membranes. Am J Obstet Gynecol 1996; 175: 1146-1151.
19. Rozenberg P, Goffinet F, Malagrida L, Giudicelli Y, Perdu M, Houssin I, Safe-Femme, Nisand I. Evaluating the risk of preterm delivery: A comparison of fetal fibronectin and transvaginal ultrasonographic measurement of cervical length. Am J Obstet Gynecol 1997; 176: 196-199.
20. Goldenberg RL, Iams JD, Mercer BM, Meis PJ, Moawad AH, Copper RL, Das A, Thom E, Johnson F, McNellis D, Miodovnik M, Van Dorsten JP, Caritis SN, Thurnau GR, Bottoms SF. The Preterm Prediction Study: The value of new vs standard risk factors in predicting early and all spontaneous preterm births. Am J Public Health 1998; 88: 233-238.
21. Heath V, Daskalakis G, Zagaliki A, Carvalho M, Nicolaides KH. Cervicovaginal fibronectin and cervical length at 23 weeks of gestation: relative risk of early preterm delivery. BJOG 2000; 107: 1276-1281.
22. Banks BA, Cnaan A, Morgan MA, Parer JT, Merrill JD, Ballard PL, Ballard RA. Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group. Am J Obstet Gynecol 1999; 181: 709-717.
23. French NP, Hagan R, Evans SF, Godfrey M, Newnham JP. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 1999; 180: 114-121.